To investigate why JMJD5 was silenced in HCC, we used DAC, a DNA methyltransferase (DNMT) inhibitor, and TSA, a histone deacetylase (HDAC) inhibitor, to treat HCC cell lines. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.